1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pemphigus Global Clinical Trials Review, H2, 2014

Pemphigus Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 69 pages

Pemphigus Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Pemphigus Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pemphigus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pemphigus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pemphigus Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Pemphigus 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Pemphigus to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Pemphigus to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Pemphigus 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Pemphigus Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Takeda Pharmaceutical Company Limited 30
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
Kemia, Inc. 32
Clinical Trial Overview of Kemia, Inc. 32
Jacobus Pharmaceutical Company 33
Clinical Trial Overview of Jacobus Pharmaceutical Company 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Genzyme Corporation 35
Clinical Trial Overview of Genzyme Corporation 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Clinuvel Pharmaceuticals Limited 37
Clinical Trial Overview of Clinuvel Pharmaceuticals Limited 37
Clinical Trial Overview of Top Institutes / Government 38
Rouen University Hospital 38
Clinical Trial Overview of Rouen University Hospital 38
Chinese Academy of Medical Sciences and Peking Union Medical College 39
Clinical Trial Overview of Chinese Academy of Medical Sciences and Peking Union Medical College 39
University Medical Center Groningen 40
Clinical Trial Overview of University Medical Center Groningen 40
Tehran University of Medical Sciences 41
Clinical Trial Overview of Tehran University of Medical Sciences 41
Postgraduate Institute of Medical Education and Research 42
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 42
Shiraz University of Medical Sciences 43
Clinical Trial Overview of Shiraz University of Medical Sciences 43
Northwestern University 44
Clinical Trial Overview of Northwestern University 44
University Hospital, Toulouse 45
Clinical Trial Overview of University Hospital, Toulouse 45
New York University School of Medicine 46
Clinical Trial Overview of New York University School of Medicine 46
Massachusetts General Hospital 47
Clinical Trial Overview of Massachusetts General Hospital 47
Five Key Clinical Profiles 48
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Pemphigus Therapeutics, Global, Clinical Trials by Region, 2014* 7
Pemphigus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pemphigus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pemphigus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Pemphigus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Pemphigus Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Pemphigus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Pemphigus to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Pemphigus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Pemphigus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Pemphigus to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Pemphigus Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Pemphigus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Pemphigus Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Pemphigus Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Pemphigus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Pemphigus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Pemphigus Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Pemphigus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Pemphigus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Pemphigus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Pemphigus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Pemphigus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 30
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 31
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Kemia, Inc., 2014* 32
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014* 33
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2014* 35
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 36
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinuvel Pharmaceuticals Limited, 2014* 37
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2014* 38
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese Academy of Medical Sciences and Peking Union Medical College, 2014* 39
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014* 40
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 41
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2014* 42
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 43
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 44
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014* 45
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 46
Pemphigus Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 47

List of Figures

Pemphigus Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Pemphigus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pemphigus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pemphigus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Pemphigus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Pemphigus Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Pemphigus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Pemphigus to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Pemphigus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Pemphigus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Pemphigus to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Pemphigus Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Pemphigus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Pemphigus Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Pemphigus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Pemphigus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Pemphigus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Pemphigus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Pemphigus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Pemphigus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Pemphigus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Pemphigus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.